| Pubmed ID |
Author | Year | Title |
22607720 |
Wang F | 2012 | Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats. |
22607767 |
Campagnoli C | 2012 | Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study. |
22607890 |
Shi D | 2012 | Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. |
22607892 |
Svendsen PF | 2012 | Adipose expression of adipocytokines in women with polycystic ovary syndrome. |
22608319 |
Will MA | 2012 | Metformin: direct inhibition of rat ovarian theca-interstitial cell proliferation. |
22610962 |
Franks S | 2012 | Animal models and the developmental origins of polycystic ovary syndrome: increasing evidence for the role of androgens in programming reproductive and metabolic dysfunction. |
22611175 |
ESHRE Capri Workshop Group. | 2012 | Health and fertility in World Health Organization group 2 anovulatory women. |
22612517 |
Genazzani AD | 2012 | Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. |
22612600 |
Palomba S | 2012 | Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study. |
22617121 |
Ouandaogo ZG | 2012 | Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo and in vitro oocyte maturation. |
22617579 |
Roth LW | 2012 | Altering hirsutism through ovulation induction in women with polycystic ovary syndrome. |
22621463 |
Sara L | 2012 | Pharmacological reactivity of resistance vessels in a rat PCOS model - vascular effects of parallel vitamin D? treatment. |
22621680 |
Bayrak T | 2012 | Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS. |
22621829 |
Zheng X | 2012 | Effect of hCG priming on embryonic development of immature oocytes collected from unstimulated women with polycystic ovarian syndrome. |
22633255 |
Veltman-Verhulst SM | 2012 | High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model for clinical practice. |
22634902 |
Sijanovi? S | 2012 | Role of laparoscopic surgery in treatment of infertility. |
22635019 |
Venturella R | 2012 | [Assessment of the modification of the clinical, endocrinal and metabolical profile of patients with PCOS syndrome treated with myo-inositol]. |
22635021 |
Nahid L | 2012 | Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome. |
22639397 |
Gao L | 2012 | Statin is a reasonable treatment option for patients with Polycystic Ovary Syndrome: a meta-analysis of randomized controlled trials. |
22639834 |
Costello MF | 2012 | The treatment of infertility in polycystic ovary syndrome: a brief update. |
22640495 |
Anderson RA | 2012 | What does anti-M?llerian hormone tell you about ovarian function? |
22641183 |
Joham AE | 2012 | Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training. |
22643321 |
Raissouni N | 2012 | Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome. |
22646322 |
Grynnerup AG | 2012 | The role of anti-M?llerian hormone in female fertility and infertility - an overview. |
22648217 |
Kim GK | 2012 | Post-adolescent acne in women: more common and more clinical considerations. |
22648908 |
Catteau-Jonard S | 2012 | Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome? |
22650028 |
Liu J | 2012 | [The role of oxidative stress in the pathogenesis of polycystic ovary syndrome]. |
22654211 |
Ma RJ | 2011 | Combination of acupuncture and chinese medicinal herbs in treating model rats with polycystic ovary syndrome. |
22654525 |
Golbahar J | 2012 | Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain. |
22655062 |
Amalfi S | 2012 | Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure. |
22658347 |
Gremeau AS | 2012 | In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles. |
22661293 |
Witchel SF | 2012 | Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. |
22662009 |
Cebeci F | 2012 | Insulin resistance in women with hirsutism. |
22668987 |
Brown RE | 2012 | Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS). |
22672538 |
Purwana IN | 2013 | Successful pregnancy after the treatment of primary amenorrhea in a patient with non-classical congenital adrenal hyperplasia. |
22672648 |
Yin Q | 2013 | Apolipoprotein B/apolipoprotein A1 ratio is a good predictive marker of metabolic syndrome and pre-metabolic syndrome in Chinese adolescent women with polycystic ovary syndrome. |
22673295 |
Li W | 2012 | Dysregulation of glucose metabolism even in Chinese PCOS women with normal glucose tolerance. |
22673409 |
Woo HY | 2012 | Differences of the association of anti-M?llerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. |
22674204 |
Zhang J | 2012 | Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS. |
22678803 |
Lin Y | 2012 | [Polymorphisms of FEM1A gene in patients with polycystic ovary syndrome]. |
22679042 |
Abdo S | 2011 | Hair, sweat and tears. |
22686091 |
Wang YH | 2012 | [Effects of compound ganshao paste on the levels of sex hormones and hepatic transaminases in polycystic ovarian syndrome rat model]. |
22686097 |
Sun JL | 2012 | [Exploration of the causes of polycystic ovary syndrome and its therapeutic mechanisms by acupuncture]. |
22693172 |
Eilertsen TB | 2012 | Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? |
22693174 |
Chen MJ | 2012 | Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome. |
22695532 |
Wang R | 2012 | Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis. |
22696324 |
Farquhar C | 2012 | Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. |
22698921 |
Gambineri A | 2012 | Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. |
22698930 |
Feigenbaum SL | 2012 | Prevalence of cervical insufficiency in polycystic ovarian syndrome. |
22699877 |
Zhang CW | 2012 | Association between polymorphisms of the CYP11A1 gene and polycystic ovary syndrome in Chinese women. |
22700441 |
Nugent BM | 2012 | Hormonal programming across the lifespan. |
22702394 |
Harmanci A | 2013 | Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome. |
22703625 |
Bayram F | 2012 | Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction. |
22703626 |
Li RH | 2012 | Management of anovulatory infertility. |
22704100 |
Panicker JN | 2012 | The possible role of opiates in women with chronic urinary retention: observations from a prospective clinical study. |
22707671 |
Chan Y | 2012 | Note of clarification of data in the meta-analysis of methylenetetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome. |
22709979 |
Codner E | 2012 | Female reproduction and type 1 diabetes: from mechanisms to clinical findings. |
22712547 |
Phelan N | 2013 | Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance. |
22713099 |
Ilie IR | 2012 | Ethinylestradiol30?g-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome? |
22714408 |
Chiang CW | 2012 | Ultraconserved elements in the human genome: association and transmission analyses of highly constrained single-nucleotide polymorphisms. |
22718099 |
Alanbay I | 2012 | A macrophage activation marker chitotriosidase in women with PCOS: does low-grade chronic inflammation in PCOS relate to PCOS itself or obesity? |
22719052 |
Ortega I | 2012 | Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of Akt/PKB signaling pathway. |
22723319 |
Jones MR | 2012 | Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. |
22723725 |
Okoroafor UC | 2012 | Incorporating patient preference into the management of infertility in women with polycystic ovary syndrome. |
22724514 |
Villa P | 2013 | Ovarian volume and gluco-insulinaemic markers in the diagnosis of PCOS during adolescence. |
22724574 |
Echibur? B | 2012 | CAG repeat polymorphism of androgen receptor gene and X-chromosome inactivation in daughters of women with polycystic ovary syndrome (PCOS): relationship with endocrine and metabolic parameters. |
22727793 |
Imbar T | 2012 | Altered endothelin expression in granulosa-lutein cells of women with polycystic ovary syndrome. |
22727921 |
Gateva AT | 2012 | Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome. |
22729136 |
Casadei L | 2012 | Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol. |
22729915 |
Tang ST | 2012 | Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with polycystic ovary syndrome: a meta-analysis. |
22730726 |
Minegishi T | 2012 | [Endocrine disease:progress in diagnosis and treatment. Topics: II. Progress in treatment; 2. Assessment and management of dysfunction of pituitary-gonad axis]. |
22733850 |
Battaglia C | 2012 | Two- and three-dimensional sonographic and color Doppler techniques for diagnosis of polycystic ovary syndrome. The stromal/ovarian volume ratio as a new diagnostic criterion. |
22737168 |
Wongwananuruk T | 2012 | The Usefulness of Homeostatic Measurement Assessment-Insulin Resistance (HOMA-IR) for Detection of Glucose Intolerance in Thai Women of Reproductive Age with Polycystic Ovary Syndrome. |
22737516 |
Behradmanesh S | 2011 | Effect of metformin on serum ferritin level in women with polycystic ovary syndrome. |
22738153 |
Knebel B | 2012 | Genetic variants in central metabolic genes influence some but not all relations of inflammatory markers in a collective with polycystic ovary syndrome. |
22740491 |
Bazarganipour F | 2012 | Psychometric properties of the Iranian version of modified polycystic ovary syndrome health-related quality-of-life questionnaire. |
22744623 |
Szydlarska D | 2012 | Measuring salivary androgens as a useful tool in the diagnosis of polycystic ovary syndrome. |
22745860 |
Shin HY | 2011 | Adiponectin in women with polycystic ovary syndrome. |
22748101 |
Agarwal A | 2012 | The effects of oxidative stress on female reproduction: a review. |
22748844 |
Li R | 2012 | Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system. |
22749225 |
Jayaprakasan K | 2012 | Prediction of in?vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women. |
22752961 |
Gonz?lez F | 2012 | Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome. |
22764561 |
Connor EL | 2012 | Adolescent polycystic ovary syndrome. |
22767467 |
Lim SS | 2012 | Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. |
22767635 |
Morgan CL | 2012 | Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. |
22768457 |
Mehrabian F | 2012 | The laparoscopic ovarian electrocautery versus gonadotropin therapy in infertile women with clomiphene citrate-resistant polycystic ovary syndrome; a randomized controlled trial. |
22771030 |
Carmina E | 2012 | Does the level of serum antim?llerian hormone predict ovulatory function in women with polycystic ovary syndrome with aging? |
22772454 |
Polzikov M | 2012 | Overexpression of ribosomal RNA in cumulus cells of patients with polycystic ovary syndrome. |
22772786 |
Palihawadana TS | 2012 | Aetiology of infertility among females seeking treatment at a tertiary care hospital in Sri Lanka. |
22774210 |
Strauss JF 3rd | 2012 | Persistence pays off for PCOS gene prospectors. |
22774396 |
Nordio M | 2012 | The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. |
22775449 |
Sprung VS | 2013 | Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies. |
22777527 |
Yildiz BO | 2012 | Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. |
22778207 |
Khan AT | 2010 | Fowler's syndrome and pregnancy. |
22778212 |
Hirsch A | 2012 | Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain. |
22778733 |
Hern?ndez-Yero A | 2012 | Diamel therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, and hyperandrogenaemia. |
22779343 |
Krysiak R | 2012 | [Current opinions on the etiology and pathophysiology of hirsutism]. |
22780885 |
Pal L | 2012 | Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. |
22781076 |
Rackow BW | 2012 | Polycystic ovary syndrome in adolescents. |
22781109 |
Yu R | 2012 | [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer]. |
Showing 10,301–10,400 of 14,368